Sequase 25 mg
Sequase 25 mg is a medicine authorised by Swissmedic under authorisation number 62331. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 September 2011 and the authorisation is valid without a time limit. ATC code N05AH04 places the medicine in the group Psycholeptics.
| Authorisation number | 62331 |
|---|---|
| Name | Sequase 25 mg |
| Full name | Sequase 25 mg, Filmtabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AH04 |
| First authorisation | 01 September 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sequase 25 mg, Filmtabletten | B | 01 September 2011 |
| 2 | Sequase 100 mg, Filmtabletten | B | 01 September 2011 |
| 3 | Sequase 200 mg, Filmtabletten | B | 01 September 2011 |
| 4 | Sequase 300 mg, Filmtabletten | B | 01 September 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 2 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 3 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 4 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 5 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 6 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 7 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sequase 25 mg authorised in Switzerland?
Yes. Sequase 25 mg is authorised by Swissmedic under authorisation number 62331, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sequase 25 mg have?
Sequase 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sequase 25 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.